Voiding Dysfunction in Women with Systemic Lupus Erythematosus

Arthritis and Rheumatism

Volumn 50, Issue 1, 2004, Pages 166-172

  Yu, Hong Jeng ^a,b   Lee, Wei Chia ^a   Lee, Kuang Lun ^a   Chen, Mao Yuan ^a   Chen, Cheng Yuan ^a   Chen, Jun ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CAPACITY; BLADDER DYSFUNCTION; BLADDER EMPTYING; BLADDER FUNCTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTOMETRY; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; HUMAN; HYDROURETER; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS; URINARY FREQUENCY; URINE FLOW RATE; URODYNAMICS;

ADULT; AGED; CYSTITIS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; URINATION DISORDERS; URODYNAMICS;

EID: 0346458584     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11431     Document Type: Article

References (26)

1. Edworthy SM. Clinical manifestations of systemic lupus erythematosus. In: Rudy S, Harris ED, Sledge CB, editors. Kelly's textbook of rheumatology. 6th ed. Philadelphia: Saunders; 2001. p. 1105-23.
2. Mills JA. Systemic lupus erythematosus. N Engl J Med 1994;30:1871-9.
3. Weisman MH, McDanald EC, Wilson CB. Studies of the pathogenesis of interstitial cystitis, obstructive uropathy, and intestinal malabsorption in a patient with systemic lupus erythematosus. Am J Med 1981;70:875-81.
4. Boye E, Morse M, Huttner I, Erlanger BF, MacKinin KJ, Klassen J. Immune complex-mediated interstitial cystitis as a major manifestation of systemic lupus erythematosus. Clin Immunol Immunopathol 1979;13:67-76.
5. Orth RW, Weisman MH, Cohen AH, Talner LB, Nachtsheim D, Zvaifler NJ. Lupus cystitis: primary bladder manifestation of systemic lupus erythematosus. Ann Intern Med 1983;98:323-6.
6. Koike T, Takabayashi K. Lupus cystitis in the Japanese. Intern Med 1996;35:87-8.
7. Alarcon-Segovia D, Abud-Mendoza C, Reyes-Gutierrez E, Iglesias-Gamarra A, Diaz-Jouanen E. Involvement of the urinary bladder in systemic lupus erythematosus: a pathologic study. J Rheumatol 1984;11:208-10.
8. Haarala M, Alanen A, Kiiholma P. Lower urinary tract symptoms in patients with Sjögren's syndrome and systemic lupus erythematosus. Int Urogynecol J 2000;11:84-6.
9. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992;148:1549-57.
10. Araki I, Kuno S. Assessment of voiding dysfunction in Parkinson's disease by the international prostate symptom score. J Neurol Neurosurg Psychiatry 2000;68:429-33.
11. Yu HJ, Chen J, Lai MK, Chan KA, Chie WC. High prevalence of voiding symptoms in Taiwanese women. Br J Urol 1998;82:520-3.
12. Groutz A, Blaivas JG, Fait A, Sassone AM, Chaikin DC, Gordon D. The significance of the American Urological Association symptom index score in the evaluation of women with bladder outlet obstruction. J Urol 2000;163:207-11.
13. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
14. Tan EM, Cohen AS, Fries JF, Masi AT, Mcshane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
15. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardization of terminology of lower urinary tract function: report from the Standardization Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:167-78.
16. Levine LA, Richie JP. Urological complications of cyclophosphamide. J Urol 1989;141:1063-9.
17. Richelson E. Pharmacology of antidepressants. Mayo Clin Proc 2001;76:511-27.
18. Maule S, Quadri R, Mirante D, Pellerito RA, Marucco E, Marinone C, et al. Autonomic nervous dysfunction in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA): possible pathogenic role of autoantibodies to autonomic nervous structures. Clin Exp Immunol 1997;110:423-7.
19. Wada T, Yokoyama H, Ikeda K, Tomosugi N, Kobayashi K. Neurogenic bladder due to peripheral neuropathy and a visual disturbance in the elderly man with systemic lupus erythematosus. Ann Rheum Dis 1992;51:547-9.
20. Hoyle C, Ewing DJ, Parker AC. Acute autonomic neuropathy in association with systemic lupus erythematosus. Ann Rheum Dis 1985;44:420-4.
21. Groutz A, Blaivas JG, Chaikin DC. Bladder outlet obstruction in women: definition and characteristics. Neurourol Urodyn 2000;19:213-20.
22. Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol 1988;140:203-6.
23. Middleton GD, McFarlin JE, Lipsky PE. The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum 1994;37:1181-8.
24. Wolfe F. Fibromyalgia: the clinical syndrome. Rheum Dis Clin North Am 1989;15:1-18.
25. Wallace DJ. Genitourinary manifestations of fibrositis: an increased association with the female urethral syndrome. J Rheumatol 1990;17:238-9.
26. Carlson KV, Fiske J, Nitti VW. Value of routine evaluation of the voiding phase when performing urodynamic testing in women with lower urinary tract symptoms. J Urol 2000;164:1614-8.